4//SEC Filing
Maryles Joel Michael 4
Accession 0001178913-22-002173
CIK 0001534248other
Filed
May 24, 8:00 PM ET
Accepted
May 25, 4:03 PM ET
Size
11.6 KB
Accession
0001178913-22-002173
Insider Transaction Report
Form 4
Maryles Joel Michael
Director
Transactions
- Award
Option to Purchase American Depositary Shares
2022-03-07+6,820→ 6,820 totalExercise: $3.53Exp: 2032-03-07→ American Depositary Shares (6,820 underlying) - Purchase
American Depositary Shares
2022-05-24$2.89/sh+400$1,156→ 1,400 total - Purchase
American Depositary Shares
2022-05-24$2.76/sh+33$91→ 1,433 total - Award
Option to Purchase American Depositary Shares
2021-04-19+11,884→ 11,884 totalExercise: $27.26Exp: 2031-04-19→ American Depositary Shares (11,884 underlying)
Footnotes (5)
- [F1]Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
- [F2]Includes the previously reported 1,000 ADSs of the Company, as reported by Mr. Joel Maryles on Form 4 filed with the SEC on March 21, 2022.
- [F3]No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
- [F4]These options vest and become exercisable in their entirety on March 16, 2023.
- [F5]These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.
Documents
Issuer
Chemomab Therapeutics Ltd.
CIK 0001534248
Entity typeother
Related Parties
1- filerCIK 0001850990
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 4:03 PM ET
- Size
- 11.6 KB